Nevertheless, there was no statistically significant difference in the concentrations of IL-6 between the NAFLD patients and the controls, which may be attributed to the small sample sizes involving IL-6. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.